By Shawn M. Carter
Healio has compiled a list of the most-read nephrology cover stories in 2023.
Readers were most interested in health equity in home dialysis, BMI requirements before transplantation, value-based care to treat chronic kidney disease and more.
Read the article in Healio.
In a recent Core Curriculum published in AJKD, James Novak and David Ellison discuss the pharmacology and therapeutic use of diuretics in states of volume overload and strategies to overcome diuretic resistance. AJKDBlog’s Interviews Editor, Timothy Yau @Maximal_Change sat down with Dr. Novak @JamesNovakNeph to discuss these topics.
Read the complete article in AJKDBlog here.
A survey of various patients in nephrology revealed that more than half knew a plant-based diet can be beneficial for chronic kidney disease, according to data published in the Journal of Renal Nutrition.
Further, 22% of participants reported following a vegetarian diet of some kind.
Read the full story from Healio.
DALLAS — After uncertainty a year ago from a leadership void at HHS, nephrology practices and kidney research are seeing benefits from recent legislative and regulatory victories, according to a speaker at the Renal Physicians Association Annual Meeting.
“A year ago, we were in the early days of the Biden Administration,” Robert Blaser, director of public policy for the RPA, said, here. “There was a lot of uncertainly this time last year.”
Read more.
For patients with both heart and kidney failure, beta-blocker use was associated with decreased mortality rates within 1 year after dialysis initiation.
According to Hui Zhou, PhD, of the department of research and evaluation at Kaiser Permanente Southern California, and colleagues, beta-blocker therapy is generally thought to be beneficial to patients with chronic kidney disease. However, they contended that less is known about its impact on patients once they progress to end-stage kidney disease and must transition to dialysis.
Read the full article, here.